Trial Profile
Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Apr 2012 Actual end date (April 2008) added as reported by ClinicalTrials.gov.
- 01 Aug 2008 Results published in the Journal of Clinical Oncology.
- 01 Jun 2007 Status changed from in progress to completed.